Search results
Results from the WOW.Com Content Network
The Bristol & West building society, registered number 2124201, was founded in 1850; 174 years ago (), originally as the "Bristol, West of England and South Wales Permanent Building Society". It offered mortgages in the Bristol and the south west of England area, and became a well-known financial services institution in the region.
The last acquisition was the deposit base and branch network of former building society Bristol & West (bringing with it approximately 700,000 customers) from Bank of Ireland in May 2005. This was the first major re-mutualisation in the United Kingdom (following the earlier demutualisation trend) and brought membership of the enlarged society ...
Cheshunt Building Society was a UK building society, which merged with the Bristol and West Building Society on 30 December 1991. [1] Bristol and West was taken over by the Bank of Ireland in 1997. Its savings balances and branch network transferred to the Britannia Building Society in 2005, which in turn merged with Co-operative Financial ...
To help offset those risks, one of the first things dividend investors do. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Mail ...
Target pays a $1.12 per share quarterly dividend for a run rate of $4.48 per year. So, even with lower profits, its earnings are still nearly double its dividend payment. With a yield of 3.4% ...
Based in New York, Bristol-Myers Squibb (NYSE:BMY) is in the Medical sector, and so far this year, shares have seen a price change of -0.96%. Why Bristol-Myers Squibb Is a Great Dividend Stock ...
Bristol and West Building Society v Mothew [1996] EWCA Civ 533 is a leading English fiduciary law and professional negligence case, concerning a solicitor's duty of care and skill, and the nature of fiduciary duties. The case is globally cited for its definition of a fiduciary and the circumstances in which a fiduciary relationship arises.
Dividend darlings Bristol-Myers and AstraZeneca are core holdings for income investors looking to offset anemic bond yields. However, rising market volatility and stubbornly low fixed income ...